Wednesday, November 8 - Sunday, November 12, 2017 Save the Date! The Society for Immunotherapy of Cancer (SITC) cordially asks you to save the date of our 32nd Annual Meeting ...
BIO Returns to California Location: San Diego Convention Center; 111 W Harbor Dr., San Diego, CA 92101 There’s no better place to connect with biotech’s top people and most innovative ...
Immunomic Therapeutics, a biotechnology company developing a new type of vaccine based on Johns Hopkins research, has reached a $300 million deal licensing its technology to Japanese company Astellas Pharma. ...
THE REMARKABLE SCIENCE BEHIND LAMP TECHNOLOGY – AND ITS POTENTIAL TO TREAT HUMAN DISEASE The body’s own immune system is its best defense against everything from allergies to cancer ...
ROCKVILLE, Md., May 16, 2016 /PRNewswire/ -- At the North Bethesda Marriott, Maryland's leading technology and life science companies gathered to celebrate recent successes from the most innovative teams in the ...
November 08, 2016 07:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced they are now accepting applications for their Cancer Discovery ...
https://www.fiercepharma.com/sponsored/reprogramming-immune-system-to-fight-cancerhttps://www.fiercepharma.com/sponsored/reprogramming-immune-system- Reprogramming the Immune System To Fight Cancer Sponsored by Immunomic Therapeutics, Inc. Nov 14, 2016 12:00am By Teri Heiland, Ph.D and Bill Watt, Ph.D. Cancer immunotherapy marks a turning ...
Clouds of pollen emanate from cedar trees in Sagamihara, Kanagawa Prefecture, in 2005. | KYODO LIFESTYLE When pollen attacks! Experts reveal new approaches to combating hay fever BY TOMOKO OTAKE ...
Immunomic is pleased to share that CEO Dr. Bill Hearl served as a panelist during The Washington Post’s Chasing Cancer Summit in Washington, D.C. on Tuesday, Dec. 7th. The event was focused ...
January 05, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces two additions to their Scientific Advisory Board. “We could not ...
Allergy treatments enter a new era — with a focus on stopping reactions before they start MEGHANA KESHAVAN @megkesh NOVEMBER 29, 2016 Allergy treatments haven’t advanced much in decades, even ...
April 27-28, 2017 Bethesda Marriott Conference Center Presented by the Maryland Technology Council, Bio+Tech17 reflects the changing landscape where life science and technology converge by bringing together more than 600 ...